Nordic Capital acquires majority share in IntegriChain, the only fully integrated platform for pharma commercialization and market access

[ad_1] Investment will accelerate IntegriChain’s ambitious growth targets and cement its status as a leading platform for pharma manufacturers to bring their science to market Further strengthens Nordic Capital’s record…

U of A launches new fund to ignite innovative ideas

[ad_1] The University of Alberta has launched a new fund to invest in startup ventures working to solve complex challenges facing the world and diversify Alberta’s economy, providing much-needed funding…

Ascend Elements and Orbia’s Koura to Explore Joint Commercialization of Advanced Graphite Recycling Technology in the United States

[ad_1] Patented Hydro-to-Anode® Graphite Recycling Technology Produces 99.9% Pure Graphite from Used Lithium-ion Batteries WESTBOROUGH, Mass., Oct. 17, 2023 /PRNewswire/ — Ascend Elements, a U.S.-based manufacturer of sustainable battery materials, and…

TIP teams up with William Davidson Institute for tech commercialization – BusinessWorld Online

[ad_1] From L-R: TIP International Relations and Linkages Officer Mandy Taller Bravo; Technology Business Incubator Program Manager/Technopreneurship Coordinator Engr. Shearyl Arenas; Vice-President for Student Affairs Dr. Frank Alejandrino; Vice-President for…

Insights into the Medical Data Commercialization Market 2023: Healthy CAGR and Business Strategy and Key Players Decided to Invest

[ad_1] Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global Medical Data Commercialization Market. The key findings and recommendations…

Commercialization of regenerative-medicine therapies – Nature Reviews Bioengineering

[ad_1] Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Related links 3/20/2017 (Humacyl): https://www.businesswire.com/news/home/20170320005777/en/Humacyte-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Expedited-Review-Designation-for-HUMACYL®-in-Vascular-Access-for-Hemodialysis 4/17/2017 (RVT-802: https://enzyvant.com/enzyvant-receives-fda-designations/ 5/2/2017 (jCell): https://www.biospace.com/article/jcyte-receives-regenerative-medicine-advanced-therapy-designation-/ 5/10/2017…

Duke Spotlight: Office for Translation & Commercialization Turns Smart Ideas into Reality | Duke Today

[ad_1] Published August 15, 2023 Unit: Office for Translation & Commercialization Years at Duke: 37 Number of employees: 42 What they are known for: When a Duke employee sprouts a…

Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China

[ad_1] SHANGHAI, April 18, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced…

Enfinity Global secures a new clean energy commercialization agreement in Italy and reaches 225 GWh in the first quarter of 2023

[ad_1] MIAMI , April 18, 2023 /PRNewswire/ — Enfinity Global Inc.(EG), a leader in renewable energy, has signed a long-term solar power purchase agreement (PPA) with Statkraft for the commercialization of…

Arrival Advances U.S. Commercialization Plans Through Business Combination with Kensington Capital Acquisition Corp. V

[ad_1] Arrival (Nasdaq: ARVL) has entered into a business combination agreement with Kensington Capital Acquisition Corp. V (NYSE: KCGI.U). Upon closing, the combined company’s ordinary shares are expected to be…